Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Stent Positioning Assistance System (SPAS)

K-Number: K221917 · 2022-08-19

Decision Date2022-08-19
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Stent Positioning Assistance System (SPAS) is a medical device manufactured by Seven Sons , Ltd.. It received FDA 510(k) clearance on 2022-08-19 under approval number K221917. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Stent Positioning Assistance System (SPAS)?

Stent Positioning Assistance System (SPAS) is a medical device that received FDA 510(k) clearance on 2022-08-19. It is manufactured by Seven Sons , Ltd.. The 510(k) number is K221917.

When was Stent Positioning Assistance System (SPAS) approved by the FDA?

Stent Positioning Assistance System (SPAS) received FDA 510(k) clearance on 2022-08-19, under approval number K221917.

What company makes Stent Positioning Assistance System (SPAS)?

Stent Positioning Assistance System (SPAS) is manufactured by Seven Sons , Ltd..

What is the FDA product code for Stent Positioning Assistance System (SPAS)?

The FDA product code for Stent Positioning Assistance System (SPAS) is DQX.

Related Clinical Trials

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.